Veno Occlusive Disease, Hepatic Completed Phase 2 / 3 Trials for Defibrotide (DB04932)

Also known as: Hepatic Veno-Occlusive Disease / Venoocclusive liver disease / Veno-occlusive disease of liver / Veno-occlusive liver disease / Veno-occlusive disease of the liver (disorder) / Venoocclusive syndrome of the liver / Sinusoidal obstruction syndrome

IndicationStatusPhase
DBCOND0105973 (Veno Occlusive Disease, Hepatic)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00272948Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of DefibrotidePrevention